Off-Label Use of Atypical Antipsychotics: An Update: Comparative Effectiveness Review Number 43 by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Off-Label Use of Atypical Antipsychotics: An Update: Comparative Effectiveness Review Number 43

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

442 pages • missing pub info (view editions)

nonfiction health
Powered by AI (Beta)
Loading...

Description

Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: th...

Read more

Community Reviews

Loading...

Content Warnings

Loading...